Menrik Biomerge Private Limited

Menrik Biomerge Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24304DL2017PTC317030 Incorporated 01 May 2017 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2024
₹13.52 Cr
▲ 4% YoY
Net profit · FY 2024
₹6.73 Lakh
Net margin 0.5%
EBITDA · FY 2024
₹18.53 Lakh
EBITDA margin 1.4%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹95 Lakh
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings

About Menrik Biomerge Private Limited

Data last updated:

Menrik Biomerge Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 May 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2017PTC317030. Its GSTIN is 07AALCM0374K2Z6 (Delhi). The company holds 3 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Vibhor Rastogi and Ketan Swaroop Bansal.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 5 Ground Floor, Manak Vihar Opp. Yojna Vihar, New Delhi, Delhi, India – 110092.

As per the financials filed for FY 2024, the company reported a revenue of ₹13.52 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹6.73 Lakh (net margin 0.5%) and EBITDA of ₹18.53 Lakh (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 17% over five years.

The company is associated with 1 brand: Menrik Biomerge. As per MCA filings, the company has open charges of ₹95 Lakh on record. Court records list 10 cases involving the company, including 7 filed by the company and 3 filed against it; 3 cases are pending.

Menrik Biomerge Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0003973). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website menrik.com.

Company details

CIN U24304DL2017PTC317030
Registration Number 317030
Incorporation Date 01 May 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-06-0003973

Recognitions & Rankings of Menrik Biomerge

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-UK-06-0003973

Contact details

Menrik Biomerge Private Limited's registered office is in New Delhi, Delhi. Its website is menrik.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Registered Address
    5 Ground Floor, Manak Vihar Opp. Yojna Vihar, New Delhi, Delhi, India – 110092
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Menrik Biomerge Private Limited, buy the company report.

Comprehensive company report
Menrik Biomerge Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Menrik Biomerge operates one associated brand: Menrik Biomerge. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical, cosmetics, and nutraceutical manufacturing and distribution services.menrik.com

Business activity

The main business activity of Menrik Biomerge is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Menrik Biomerge Private Limited, buy the company report.

Financials of Menrik Biomerge Private Limited

FY 2024 filings available

Menrik Biomerge Private Limited reported revenue of ₹13.52 Cr (up 4% YoY) for FY 2024.

Revenue · FY 2024
₹13.52 Cr ▲ 4%
Net profit · FY 2024
₹6.73 Lakh margin 0.5%
EBITDA · FY 2024
₹18.53 Lakh margin 1.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 4%
5 years · compounded
▲ 17%
EBITDA CAGR growth
3 years · compounded
▼ 9%
5 years · compounded
▼ 6%

Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 4% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹18.53 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹6.73 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin1.4%
Net Profit Margin0.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Menrik Biomerge Private Limited, buy the company report.

Board of directors of Menrik Biomerge Private Limited

Menrik Biomerge has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Vibhor RastogiDirector01 May 20179 Years 6 MonthsCurrent
Ketan Swaroop BansalDirector01 May 20179 Years 6 MonthsCurrent

Peer comparison

Menrik Biomerge Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
M Sea Pharmaceuticals Private Limited₹13.67 Cr (FY 2024)-3.0%Himachal Pradesh, India
Chaitanya Life Science Private Limited₹13.59 Cr (FY 2024)364.0%Jhagadia, Gujarat, India
Caplet Health Care Private Limited₹13.53 Cr (FY 2025)11.0%Kolkata, West Bengal, India
Menrik Biomerge Private Limitedthis company₹13.52 Cr (FY 2024)₹6.73 Lakh0.5%4.0%New Delhi, Delhi, India
Dhwanilife Care Private Limited₹13.5 Cr (FY 2024)85.0%Ahmedabad, Gujarat, India
KNM Pharma Private Limited₹13.41 Cr (FY 2025)36.0%Ahmedabad, Gujarat, India

To see the full peer comparison of Menrik Biomerge Private Limited, buy the company report.

Auditor

Menrik Biomerge Private Limited is audited by Jitender R Deo & Company for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Jitender R Deo & CompanyFY 2023019127N

Shareholding

The shareholding of Menrik Biomerge Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Menrik Biomerge Private Limited, buy the company report.

Charges & borrowings

Open charges
₹95 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.95 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
31 Dec 2018100241714Others₹95 LakhOpen

To see the full charge records of Menrik Biomerge Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Menrik Biomerge Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Menrik Biomerge has 3 GST registrations: 2 active and 1 cancelled or inactive.

Total GSTINs
3
Active
2
Cancelled / inactive
1
GSTINStateStatusRegistered on
07AALCM0374K2Z6DelhiActive01 Nov 2018
05AALCM0374K1ZBUttarakhandActive27 Jul 2017

To see the full GST registrations and return filing status of Menrik Biomerge Private Limited, buy the company report.

Recent activity

Menrik Biomerge Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Ketan Swaroop Bansal was appointed as Director on 01 May 2017.

AGM
Menrik Biomerge Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Menrik Biomerge Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Others of Rs. 95.00 Lakh registered on 31 Dec 2018 with Charge ID 100241714 was modified on 10 Jul 2020.
Charges
A charge with Others amounted to Rs. 95.00 Lakh with Charge ID 100241714 was registered on 31 Dec 2018.
Appointed
Ketan Swaroop Bansal was appointed as Director.
Appointed
Vibhor Rastogi was appointed as Director.
Incorporation
01 May 2017
Menrik Biomerge Private Limited was registered on 01 May 2017 with Roc Delhi & aged 9 years 6 months as per MCA records.

Frequently asked questions

Menrik Biomerge is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 May 2017 (9+ years old) and is registered under CIN U24304DL2017PTC317030.

Menrik Biomerge has 2 current directors:

The latest financial statements of Menrik Biomerge on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Menrik Biomerge is 07AALCM0374K2Z6, registered in Delhi. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 05AALCM0374K1ZB (Uttarakhand).

The CIN (Corporate Identification Number) of Menrik Biomerge is U24304DL2017PTC317030. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Menrik Biomerge has 10 court cases on record: 7 filed by the company and 3 filed against it. 3 are pending. Most are in the district courts.

Menrik Biomerge was incorporated on 01 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Menrik Biomerge by revenue are M Sea Pharmaceuticals Private Limited, Chaitanya Life Science Private Limited, Caplet Health Care Private Limited, Dhwanilife Care Private Limited, KNM Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Ketan Swaroop Bansal was appointed as Director on 01 May 2017. Vibhor Rastogi was appointed as Director on 01 May 2017.

Yes, Menrik Biomerge is registered as a small enterprise under Udyam registration (number: UDYAM-UK-06-0003973).

Menrik Biomerge can be reached through the website menrik.com. Its registered office is in New Delhi, Delhi, India.